BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12393549)

  • 21. Extended in vitro expansion of adult, mobilized CD34+ cells without significant cell senescence using a stromal cell coculture system with single cytokine support.
    Weisel KC; Moore MA; Kanz L; Möhle R
    Stem Cells Dev; 2009 Mar; 18(2):229-34. PubMed ID: 18491948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biosimilar Filgrastim (Tevagrastim, XMO2) for Allogeneic Hematopoietic Stem Cell Mobilization and Transplantation in Patients with Acute Myelogenous Leukemia/Myelodysplastic Syndromes.
    Danylesko I; Sareli R; Bloom-Varda N; Yerushalmi R; Shem-Tov N; Shimoni A; Nagler A
    Biol Blood Marrow Transplant; 2016 Feb; 22(2):277-283. PubMed ID: 26343949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mononuclear Cell Telomere Attrition Is Associated with Overall Survival after Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancies.
    Helby J; Petersen SL; Kornblit B; Nordestgaard BG; Mortensen BK; Bojesen SE; Sengeløv H
    Biol Blood Marrow Transplant; 2019 Mar; 25(3):496-504. PubMed ID: 30266676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Telomere shortening in hematopoietic stem cell transplantation: a potential mechanism for late graft failure?
    Awaya N; Baerlocher GM; Manley TJ; Sanders JE; Mielcarek M; Torok-Storb B; Lansdorp PM
    Biol Blood Marrow Transplant; 2002; 8(11):597-600. PubMed ID: 12463478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Absence of donor-derived keratinocyte stem cells in skin tissues cultured from patients after mobilized peripheral blood hematopoietic stem cell transplantation.
    Hematti P; Sloand EM; Carvallo CA; Albert MR; Yee CL; Fuehrer MM; Blancato JK; Kearns WG; Barrett JA; Childs RW; Vogel JC; Dunbar CE
    Exp Hematol; 2002 Aug; 30(8):943-9. PubMed ID: 12160846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mobilization of hematopoietic progenitors from normal donors using the combination of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor results in fewer plasmacytoid dendritic cells in the graft and enhanced donor T cell engraftment with Th1 polarization: results from a randomized clinical trial.
    Lonial S; Akhtari M; Kaufman J; Torre C; Lechowicz MJ; Flowers C; Sinha R; Khoury HJ; Langston AA; Waller EK
    Biol Blood Marrow Transplant; 2013 Mar; 19(3):460-7. PubMed ID: 23201472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peripheral blood stem cell mobilization: the CXCR2 ligand GRObeta rapidly mobilizes hematopoietic stem cells with enhanced engraftment properties.
    Pelus LM; Fukuda S
    Exp Hematol; 2006 Aug; 34(8):1010-20. PubMed ID: 16863907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of accessory cells in allogeneic peripheral blood stem cell transplantation.
    Tanaka J; Imamura M; Kasai M; Asaka M; Torok-Storb B
    Int J Hematol; 1999 Feb; 69(2):70-4. PubMed ID: 10071453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cellular mechanism for granulocyte-colony stimulating factor in the prevention of graft-versus-host disease in combined bone marrow and peripheral blood transplantation for hematological malignancies: the composition in collection.
    Zhang C; Zhang X; Chen XH
    Transfus Apher Sci; 2013 Feb; 48(1):3-9. PubMed ID: 23279971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peripheral Blood Stem Cell Mobilization in Healthy Donors by Granulocyte Colony-Stimulating Factor Causes Preferential Mobilization of Lymphocyte Subsets.
    Melve GK; Ersvaer E; Eide GE; Kristoffersen EK; Bruserud Ø
    Front Immunol; 2018; 9():845. PubMed ID: 29770133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Superior GVHD-free, relapse-free survival for G-BM to G-PBSC grafts is associated with higher MDSCs content in allografting for patients with acute leukemia.
    Fan Q; Liu H; Liang X; Yang T; Fan Z; Huang F; Ling Y; Liao X; Xuan L; Xu N; Xu X; Ye J; Liu Q
    J Hematol Oncol; 2017 Jul; 10(1):135. PubMed ID: 28676100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Telomere biology in hematopoiesis and stem cell transplantation.
    Gadalla SM; Savage SA
    Blood Rev; 2011 Nov; 25(6):261-9. PubMed ID: 21764192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The composition of leukapheresis products impacts on the hematopoietic recovery after autologous transplantation independently of the mobilization regimen.
    Menéndez P; Caballero MD; Prosper F; Del Cañizo MC; Pérez-Simón JA; Mateos MV; Nieto MJ; Corral M; Romero M; García-Conde J; Montalbán MA; San Miguel JF; Orfao A
    Transfusion; 2002 Sep; 42(9):1159-72. PubMed ID: 12430673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accelerated telomere shortening in hematological lineages is limited to the first year following stem cell transplantation.
    Rufer N; Brümmendorf TH; Chapuis B; Helg C; Lansdorp PM; Roosnek E
    Blood; 2001 Jan; 97(2):575-7. PubMed ID: 11154240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytokine-mobilized peripheral blood progenitor cells for allogeneic reconstitution of miniature swine.
    Colby C; Chang Q; Fuchimoto Y; Ferrara V; Murphy M; Sackstein R; Spitzer TR; White-Scharf ME; Sachs DH
    Transplantation; 2000 Jan; 69(1):135-40. PubMed ID: 10653392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
    Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
    Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progenitor content of autologous grafts: mobilized bone marrow vs mobilized blood.
    Dahl E; Burroughs J; DeFor T; Verfaillie C; Weisdorf D
    Bone Marrow Transplant; 2003 Sep; 32(6):575-80. PubMed ID: 12953129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hematologic recovery in patients who are treated with autologous stem cells transplantation taken from bone marrow after granulocyte-colony-stimulating factor stimulation.
    Gawronski K; Rzepecki P; Oborska S; Wasko-Grabowska A
    Transplant Proc; 2011 Oct; 43(8):3114-5. PubMed ID: 21996240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effects of protocol HX-97 on mobilization, collection and hematopoietic reconstitution of peripheral blood stem cells transplantation].
    Liu T; Jia Y; Lu Z; Qin L; Xu C; Wu J; Deng C
    Hua Xi Yi Ke Da Xue Xue Bao; 1999 Dec; 30(4):428-30. PubMed ID: 11387960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of Recipient Age and Stem Cell Source on the Association between Donor Telomere Length and Survival after Allogeneic Unrelated Hematopoietic Cell Transplantation for Severe Aplastic Anemia.
    Gadalla SM; Wang T; Dagnall C; Haagenson M; Spellman SR; Hicks B; Jones K; Katki HA; Lee SJ; Savage SA
    Biol Blood Marrow Transplant; 2016 Dec; 22(12):2276-2282. PubMed ID: 27641680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.